AvoMD recognized for bringing evidence into the clinical workflow to drive efficiency and improve outcomes
NEW YORK, December 5, 2023 - CB Insights today named AvoMD to its fifth-annual Digital Health 50 (formerly the Digital Health 150), showcasing the 50 most promising private digital health companies of 2023.
"From bringing clinical trials to underserved populations to developing new drugs and therapies, this year’s Digital Health 50 winners are transforming the future of healthcare,” said Alex Lennox-Miller, CB Insights’ Lead Healthcare Analyst. “Generative AI is continuing to gain traction in healthcare, with over thirty companies in this year’s cohort offering AI-augmented solutions. We are excited to follow the meaningful impact, industry-leading innovations, and continued success of this year’s winners.”
"We are honored to be recognized by CB Insights as we strive to create the most-loved clinician support platform that healthcare organizations use to standardize care without the technical hassle," said AvoMD Co-Founder and Head of Product and Engineering, Joongheum Park, M.D. "AvoMD's platform has a unique ability to centralize key clinical and system-specific knowledge and transform that into actionable tools in the clinician workflow. By leveraging the latest technology and AI, AvoMD drives efficiencies for clinicians and helps them improve care delivery, in a way that has never been done before in the clinical decision support ecosystem."
The 50 winners were selected from a pool of over 10K companies, including applicants and nominees. They were chosen based on several factors, including CB Insights datasets — covering R&D activity, Mosaic scores, business relationships, software buyer transcripts, investor profiles, news sentiment analysis, competitive landscape, and team strength — along with criteria such as tech novelty, market potential, and impact on the industry.
AvoMD empowers healthcare organizations to standardize care by driving clinician adoption of key initiatives across quality, cost reduction, and reimbursement. Its easy-to-use "Builder" allows for quick customization, deployment, and maintenance of clinician-facing tools in the EHR with minimal-to-no technical resources.
About CB Insights:
CB Insights builds software that enables the world's best companies to discover, understand, and make technology decisions with confidence. By marrying data, expert insights, and work management tools, clients manage their end-to-end technology decision-making process on CB Insights. To learn more, please visit www.cbinsights.com.
AvoMD is a software platform that transforms clinical evidence - guidelines, pathways, and algorithms - into the workflow, available in the EHR or as a standalone web/mobile application. AvoMD automates the ordering and documentation processes in addition to providing clinical guidelines in real-time, point-of-care optimized formats. Randomized control trials and implementations demonstrate that AvoMD saves clinicians over 50% of their time in clinical decision-making at the bedside while improving outcomes and reducing costs. For more information, visit www.avomd.com or email firstname.lastname@example.org.